To the Editor Dr Thom and colleagues1 addressed medication adherence by analyzing the effects of an FDC pill for patients with or at high risk of cardiovascular disease. Thom et al1 assessed participants at 6-month intervals for a minimum of 12 months up to a maximum of 24 months from the initial intervention.